Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test
Healgen Rapid Check® COVID-19/Flu A&B Antigen Test was supported through the Independent Test Assessment Program (ITAP), a National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program. HOUSTON, Oct. 8, 2024 /PRNewswire/ -- Healgen Scientific LLC, a leading innovator in diagnostic solutions, announced the U.S. Food and Drug Administration (FDA) has...
Pop culture meets a sense of wellbeing: inspiring ToyTrends for Spielwarenmesse 2025
Two new trends: 'Anime & Friends' and 'Healthy Heroes' Perfect position: new central location at Eingang Mitte NUREMBERG, Germany, Oct. 8, 2024 /PRNewswire/ -- From 28 January to 1 February 2025, Nuremberg will again become the centre of the global toy sector. The international TrendCommittee, together with the Spielwarenmesse team, has identified two ToyTrends for the coming...
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections
FOSTER CITY, Calif., Oct. 8, 2024 /PRNewswire/ -- MicuRx Pharmaceuticals is excited to announce the publication of groundbreaking research on MRX-5, a novel oral oxaborole prodrug, demonstrating significant potential in the treatment of pulmonary infections caused by Mycobacterium abscessus (Mab), a severe nontuberculous mycobacterium (NTM) infection. The research was led by Dr. Gyanu Lamichhane, Associate Professor at Johns Hopkins...
Herbalife Sets GUINNESS WORLD RECORDS™ Title with 2024 Worldwide Workout
More than 4,900 fitness enthusiasts from around the world participated in a high-intensity interval training workout LOS ANGELES, Oct. 8, 2024 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, has made history by setting a new GUINNESS WORLD RECORDS title for the largest high-intensity interval training class (multiple venues)....
Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC
ROCKVILLE, Md. and SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that APG-2449, a FAK/ALK/ROS1 tyrosine kinase inhibitor (TKI), has been cleared by the Center for Drug Evaluation...
Sciwind Biosciences Announces Oral Presentation on Oral GLP-2 Research Progress at the 32nd United European Gastroenterology Week (UEG Week 2024)
BEIJING and HANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- The 32nd United European Gastroenterology Week (UEG Week 2024) will take place in Vienna, Austria, from October 12 to 15, 2024. UEG Week is the largest gastroenterology conference in Europe and one of the leading meetings worldwide. It brings together gastroenterology experts, physicians, researchers, and industry representatives from around the...
Empowering Elder Care: DKSH’s Mission for “Patient Purpose Day 2024”
For the second consecutive year, DKSH Healthcare Business Unit is marking "Patient Purpose Day 2024" with a series of impactful initiatives across Asia dedicated to elder care. These programs, which include health screenings, educational workshops, and donation drives, aim to meet the needs of the aging population and promote healthy aging through...
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy
SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announced a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen will lead a global clinical study to evaluate the therapeutic potential of the combination of MediLink's B7-H3-targeting antibody-drug conjugate (ADC) YL201...
Meridian Innovation Secures US$12.5 Million in Funding from Strategic Partner, Existing Investors and New Investors to Accelerate Growth
SINGAPORE, Oct. 8, 2024 /PRNewswire/ -- Meridian Innovation Pte Ltd, the pioneer developer of low cost, mass producible thermal imaging sensors, is pleased to announce it has raised US$12.5 million in a funding round led by new investors, strategic partners, as well as participation from existing investors. This funding will enable Meridian...
Korean and Brazilian doctors take anti-aging thread lifting technology classes at Juan Clinic in Korea
SEOUL, South Korea, Oct. 8, 2024 /PRNewswire/ -- In early September this year, Juan Clinic hosted a live training session for around 150 Korean and Brazilian doctors, where Korean directors with extensive experience in thread lifting procedures for wrinkle reduction shared their expertise. About 60 Brazilian doctors participated in the live sessions, which featured five distinct courses, allowing them...














